BeOne Medicines Ltd.
Ticker: 1651308
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 1.5K+7.2% | 1.4K+7.4% | 1.3K+17.7% | 1.1K+11.5% | 1.0K+7.8% | 929.17+23.6% | 751.65-3.8% | 781.31 |
| Total Income | 1.5K+7.2% | 1.4K+7.4% | 1.3K+17.7% | 1.1K+11.5% | 1.0K+7.8% | 929.17+23.6% | 751.65-3.8% | 781.31 |
| EXPENSES | ||||||||
| Expenditure | 1.1K+4.1% | 1.1K-1.0% | 1.1K+12.9% | 941.18-1.1% | 951.40+5.9% | 898.20+1.1% | 888.07-3.0% | 915.28 |
| Tax | 31.86+42.7% | 22.32+326.8% | 5.23-73.4% | 19.63-14.8% | 23.05+59.1% | 14.49+87.7% | 7.72-44.6% | 13.93 |
| PROFIT | ||||||||
| PBT | 259.22+76.1% | 147.16+47.8% | 99.55+376.3% | 20.90+121.3% | -98.30+7.2% | -105.92+56.5% | -243.43-206.1% | 229.34 |
| Net Profit | 227.36+82.1% | 124.84+32.4% | 94.32+7326.8% | 1.27+101.0% | -121.35-0.8% | -120.41+52.1% | -251.15-216.6% | 215.41 |
| KEY METRICS | ||||||||
| OPM % | 16.51%+4.96pp | 11.55%+4.87pp | 6.68%+5.69pp | 0.99%+13.00pp | -12.01%-0.47pp | -11.53%+23.24pp | -34.77%-17.62pp | -17.15% |
| NPM % | 15.02%+6.18pp | 8.84%+1.67pp | 7.17%+7.06pp | 0.11%+12.23pp | -12.12%+0.84pp | -12.96%+20.45pp | -33.41%-60.98pp | 27.57% |
| EPS | 0.16+77.8% | 0.09+28.6% | 0.07 | 0.00+100.0% | -0.09+0.0% | -0.09+52.6% | -0.19-218.8% | 0.16 |
Corporate Events
Board MeetingONC
202611Jun
Board Meeting
Annual General Meeting held to approve financial statements,…
SEC Filing ↗